116 related articles for article (PubMed ID: 34808257)
1. CCL8 deficiency in the host abrogates early mortality of acute graft-versus-host disease in mice with dysregulated IL-6 expression.
Igarashi K; Hori T; Yamamoto M; Sohma H; Suzuki N; Tsutsumi H; Kawasaki Y; Kokai Y
Exp Hematol; 2022 Feb; 106():47-57. PubMed ID: 34808257
[TBL] [Abstract][Full Text] [Related]
2. Early expression of plasma CCL8 closely correlates with survival rate of acute graft-vs.-host disease in mice.
Yamamoto M; Ota A; Hori T; Imai S; Sohma H; Suzuki N; Hatakeyama N; Inazawa N; Ito YM; Kimura H; Tsutsumi H; Kokai Y
Exp Hematol; 2011 Nov; 39(11):1101-12. PubMed ID: 21782767
[TBL] [Abstract][Full Text] [Related]
3. Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10.
Lamarthée B; Malard F; Gamonet C; Bossard C; Couturier M; Renauld JC; Mohty M; Saas P; Gaugler B
Mucosal Immunol; 2016 Mar; 9(2):309-21. PubMed ID: 26153763
[TBL] [Abstract][Full Text] [Related]
4. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
Front Immunol; 2018; 9():2724. PubMed ID: 30534126
[TBL] [Abstract][Full Text] [Related]
5. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of plasma CCL8 in mouse model of graft-vs-host disease.
Ota A; Yamamoto M; Hori T; Miyai S; Naishiro Y; Sohma H; Maeda M; Kokai Y
Exp Hematol; 2009 Apr; 37(4):525-31. PubMed ID: 19302923
[TBL] [Abstract][Full Text] [Related]
7. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
9. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
Front Immunol; 2021; 12():647894. PubMed ID: 34262560
[TBL] [Abstract][Full Text] [Related]
10. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
[TBL] [Abstract][Full Text] [Related]
11. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
12. CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease.
Hori T; Naishiro Y; Sohma H; Suzuki N; Hatakeyama N; Yamamoto M; Sonoda T; Mizue Y; Imai K; Tsutsumi H; Kokai Y
Blood; 2008 Apr; 111(8):4403-12. PubMed ID: 18256320
[TBL] [Abstract][Full Text] [Related]
13. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M
Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of Acute GVHD Mouse Model of Haplo identical Hematopoietic Stem Cell Transplantation and Its Pathogenesis].
Shao L; Zhang Y; Zhou FL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1165-1171. PubMed ID: 28823287
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Cavet J; Dickinson AM; Norden J; Taylor PR; Jackson GH; Middleton PG
Blood; 2001 Sep; 98(5):1594-600. PubMed ID: 11520812
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B
Front Immunol; 2020; 11():181. PubMed ID: 32117306
[TBL] [Abstract][Full Text] [Related]
18. R707, a fully human antibody directed against CC-chemokine receptor 7, attenuates xenogeneic acute graft-versus-host disease.
Fowler KA; Vasilieva V; Ivanova E; Rimkevich O; Sokolov A; Abbasova S; Kim E; Coghill JM
Am J Transplant; 2019 Jul; 19(7):1941-1954. PubMed ID: 30748092
[TBL] [Abstract][Full Text] [Related]
19. Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage.
He X; Ye Y; Xu X; Wang J; Huang Y; Weng G; Zhang M; Guo K
Biomed Res Int; 2016; 2016():3071214. PubMed ID: 27843940
[TBL] [Abstract][Full Text] [Related]
20. Recipient-derived IL-22 alleviates murine acute graft-versus-host disease in association with reduced activation of antigen presenting cells.
Pan B; Xia F; Wu Y; Zhang F; Lu Z; Fu R; Shang L; Li L; Sun Z; Zeng L; Xu K
Cytokine; 2018 Nov; 111():33-40. PubMed ID: 30114627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
